306 related articles for article (PubMed ID: 26621832)
21. [Transcriptional inhibition of human papilloma virus in cervical carcinoma cells reactivates functions of the tumor suppressor p53].
Kochetkov DV; Il'inskaia GV; Komarov PG; Strom E; Agapova LS; Ivanov AV; Budanov AV; Frolova EI; Chumakov PM
Mol Biol (Mosk); 2007; 41(3):515-23. PubMed ID: 17685229
[TBL] [Abstract][Full Text] [Related]
22. Potential Antitumor Effects of 6-Gingerol in p53-Dependent Mitochondrial Apoptosis and Inhibition of Tumor Sphere Formation in Breast Cancer Cells.
Sp N; Kang DY; Lee JM; Bae SW; Jang KJ
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925065
[TBL] [Abstract][Full Text] [Related]
23. Sequential effects of the proteasome inhibitor bortezomib and chemotherapeutic agents in uterine cervical cancer cell lines.
Miyamoto Y; Nakagawa S; Wada-Hiraike O; Seiki T; Tanikawa M; Hiraike H; Sone K; Nagasaka K; Oda K; Kawana K; Nakagawa K; Fujii T; Yano T; Kozuma S; Taketani Y
Oncol Rep; 2013 Jan; 29(1):51-7. PubMed ID: 23064281
[TBL] [Abstract][Full Text] [Related]
24. Recombinant adenovirus-p53 gene transfer and cell-specific growth suppression of human cervical cancer cells in vitro and in vivo.
Ahn WS; Bae SM; Lee KH; Lee JM; Namkoong SE; Chun HJ; Kim CK; Kim YW
Gynecol Oncol; 2004 Feb; 92(2):611-21. PubMed ID: 14766255
[TBL] [Abstract][Full Text] [Related]
25. A cyano analogue of boswellic acid induces crosstalk between p53/PUMA/Bax and telomerase that stages the human papillomavirus type 18 positive HeLa cells to apoptotic death.
Khan S; Chib R; Shah BA; Wani ZA; Dhar N; Mondhe DM; Lattoo S; Jain SK; Taneja SC; Singh J
Eur J Pharmacol; 2011 Jun; 660(2-3):241-8. PubMed ID: 21440536
[TBL] [Abstract][Full Text] [Related]
26. Chemoradiation of cervical cancer cells: targeting human papillomavirus E6 and p53 leads to either augmented or attenuated apoptosis depending on the platinum carrier ligand.
Koivusalo R; Krausz E; Ruotsalainen P; Helenius H; Hietanen S
Cancer Res; 2002 Dec; 62(24):7364-71. PubMed ID: 12499281
[TBL] [Abstract][Full Text] [Related]
27. Assessment of anti-cancerous potential of 6-gingerol (Tongling White Ginger) and its synergy with drugs on human cervical adenocarcinoma cells.
Zhang F; Zhang JG; Qu J; Zhang Q; Prasad C; Wei ZJ
Food Chem Toxicol; 2017 Nov; 109(Pt 2):910-922. PubMed ID: 28249781
[TBL] [Abstract][Full Text] [Related]
28. RNA interference against HPV16 E7 oncogene leads to viral E6 and E7 suppression in cervical cancer cells and apoptosis via upregulation of Rb and p53.
Sima N; Wang W; Kong D; Deng D; Xu Q; Zhou J; Xu G; Meng L; Lu Y; Wang S; Ma D
Apoptosis; 2008 Feb; 13(2):273-81. PubMed ID: 18060502
[TBL] [Abstract][Full Text] [Related]
29. Regulation of p53 expression and apoptosis by vault RNA2-1-5p in cervical cancer cells.
Kong L; Hao Q; Wang Y; Zhou P; Zou B; Zhang YX
Oncotarget; 2015 Sep; 6(29):28371-88. PubMed ID: 26318295
[TBL] [Abstract][Full Text] [Related]
30. Novel action modality of the diterpenoid anisomelic acid causes depletion of E6 and E7 viral oncoproteins in HPV-transformed cervical carcinoma cells.
Paul P; Rajendran SK; Peuhu E; Alshatwi AA; Akbarsha MA; Hietanen S; Eriksson JE
Biochem Pharmacol; 2014 May; 89(2):171-84. PubMed ID: 24565908
[TBL] [Abstract][Full Text] [Related]
31. Antiviral agent Cidofovir restores p53 function and enhances the radiosensitivity in HPV-associated cancers.
Abdulkarim B; Sabri S; Deutsch E; Chagraoui H; Maggiorella L; Thierry J; Eschwege F; Vainchenker W; Chouaïb S; Bourhis J
Oncogene; 2002 Apr; 21(15):2334-46. PubMed ID: 11948417
[TBL] [Abstract][Full Text] [Related]
32. Selective silencing of viral gene expression in HPV-positive human cervical carcinoma cells treated with siRNA, a primer of RNA interference.
Jiang M; Milner J
Oncogene; 2002 Sep; 21(39):6041-8. PubMed ID: 12203116
[TBL] [Abstract][Full Text] [Related]
33. Silencing of HPV 18 oncoproteins With RNA interference causes growth inhibition of cervical cancer cells.
Lea JS; Sunaga N; Sato M; Kalahasti G; Miller DS; Minna JD; Muller CY
Reprod Sci; 2007 Jan; 14(1):20-8. PubMed ID: 17636212
[TBL] [Abstract][Full Text] [Related]
34. Crucial role of TSC-22 in preventing the proteasomal degradation of p53 in cervical cancer.
Yoon CH; Rho SB; Kim ST; Kho S; Park J; Jang IS; Woo S; Kim SS; Lee JH; Lee SH
PLoS One; 2012; 7(8):e42006. PubMed ID: 22870275
[TBL] [Abstract][Full Text] [Related]
35. Human Papillomavirus E6/E7-Specific siRNA Potentiates the Effect of Radiotherapy for Cervical Cancer in Vitro and in Vivo.
Jung HS; Rajasekaran N; Song SY; Kim YD; Hong S; Choi HJ; Kim YS; Choi JS; Choi YL; Shin YK
Int J Mol Sci; 2015 May; 16(6):12243-60. PubMed ID: 26035754
[TBL] [Abstract][Full Text] [Related]
36. [Relationship between nitric oxide in cervical microenvironment and different HPV types and effect on cervical cancer cells].
Wei XM; Wang Q; Gao SJ; Sui L
Zhonghua Fu Chan Ke Za Zhi; 2011 Apr; 46(4):260-5. PubMed ID: 21609578
[TBL] [Abstract][Full Text] [Related]
37. Apoptosis induced by an antagonist peptide against HPV16 E7 in vitro and in vivo via restoration of p53.
Guo C; Liu K; Zheng Y; Luo H; Chen H; Huang L
Apoptosis; 2011 Jun; 16(6):606-18. PubMed ID: 21475994
[TBL] [Abstract][Full Text] [Related]
38. Neocarzinostatin induces an effective p53-dependent response in human papillomavirus-positive cervical cancer cells.
Bañuelos A; Reyes E; Ocadiz R; Alvarez E; Moreno M; Monroy A; Gariglio P
J Pharmacol Exp Ther; 2003 Aug; 306(2):671-80. PubMed ID: 12750435
[TBL] [Abstract][Full Text] [Related]
39. COP9 signalosome subunit 6 (CSN6) regulates E6AP/UBE3A in cervical cancer.
Gao S; Fang L; Phan LM; Qdaisat A; Yeung SC; Lee MH
Oncotarget; 2015 Sep; 6(29):28026-41. PubMed ID: 26318036
[TBL] [Abstract][Full Text] [Related]
40. Rescue of p53 function by small-molecule RITA in cervical carcinoma by blocking E6-mediated degradation.
Zhao CY; Szekely L; Bao W; Selivanova G
Cancer Res; 2010 Apr; 70(8):3372-81. PubMed ID: 20395210
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
